CARDIOPROTECTION BY ANGIOTENSIN-CONVERTING ENZYME-INHIBITORS - THE EXPERIMENTAL-EVIDENCE

被引:52
作者
PARRATT, JR
机构
[1] Department of Physiology and Pharmacology, University of Strathclyde
基金
英国惠康基金;
关键词
D O I
10.1093/cvr/28.2.183
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
[No abstract available]
引用
收藏
页码:183 / 189
页数:7
相关论文
共 97 条
[1]  
ALBUS U, 1987, Naunyn-Schmiedeberg's Archives of Pharmacology, V335, pR82
[2]  
BAUUMGARTENCR, 1993, BRIT J PHARMACOL, V108, P293
[3]   PHARMACOLOGICAL INTERFERENCE WITH THE CARDIAC RENIN-ANGIOTENSIN SYSTEM [J].
BECKER, RHA ;
LINZ, W ;
SCHOLKENS, BA .
JOURNAL OF CARDIOVASCULAR PHARMACOLOGY, 1989, 14 :S10-S15
[4]  
BECKER RHA, 1987, AM J CARDIOL, V50, pD3
[5]  
BOSSALLER C, 1992, AGENT ACTION SUPPL, V38, P171
[6]  
BROWN E J JR, 1988, Journal of the American College of Cardiology, V11, p50A
[7]  
BUSSE R, 1991, N-S ARCH PHARMACOL, V344, P126
[8]   RAMIPRILAT ATTENUATES THE LOCAL RELEASE OF NORADRENALINE IN THE ISCHEMIC MYOCARDIUM [J].
CARLSSON, L ;
ABRAHAMSSON, T .
EUROPEAN JOURNAL OF PHARMACOLOGY, 1989, 166 (02) :157-164
[9]   PROTECTIVE EFFECTS OF BRADYKININ ON THE ISCHEMIC HEART - IMPLICATION OF THE B1 RECEPTOR [J].
CHAHINE, R ;
ADAM, A ;
YAMAGUCHI, N ;
GASPO, R ;
REGOLI, D ;
NADEAU, R .
BRITISH JOURNAL OF PHARMACOLOGY, 1993, 108 (02) :318-322
[10]   ENALAPRIL IN THE PREVENTION OF RESTENOSIS FOLLOWING INTRACORONARY INTERVENTION IN A SWINE MODEL [J].
CHURCHILL, DA ;
SIEGEL, CO ;
MINOR, ST ;
WEST, MS ;
RAIZNER, AE .
CORONARY ARTERY DISEASE, 1993, 4 (05) :461-467